Secernin-1 Contributes to Colon Cancer Progression through Enhancing Matrix Metalloproteinase-2/9 Exocytosis

Table 1

Expression of SCRN1 protein in normal mucosa, cancerous tissue, and LNM tissues.

Tissue sample		SCRN1 expression		value
		Negative and weak (, %)	Moderate and strong (, %)
Normal mucosa	117	83 (70.9%)	34 (29.1%)
Cancerous tissue	117	55 (47.0%)	62 (53.0%)	<0.001^a
LNM tissue	42	17 (40.5%)	25 (59.5%)	<0.001^b

SCRN1: Secernin-1; LNM: lymph node metastasis.
^aSignificant difference between cancerous tissues and normal mucosa in SCRN1 expression.
^bSignificant difference between LNM tissues and normal mucosa in SCRN1 expression.